Restore Protections for Dialysis Patients Act
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
This bill, the Restore Protections for Dialysis Patients Act, aims to strengthen protections for individuals with end-stage renal disease (ESRD) who rely on Medicare coverage. It specifically prohibits private health insurers from unfairly limiting benefits or network access based on a patient’s ESRD diagnosis. The bill clarifies that insurers cannot treat dialysis care differently than other covered medical services and prevents them from shifting primary responsibility for costs to Medicare. It reinforces Congress’s intention to ensure equitable coverage for ESRD patients.
Key provisions
- Prohibits private health insurers from differentiating benefits based on ESRD diagnosis.
- Prevents insurers from limiting network composition in a way that disproportionately affects ESRD patients.
- Prevents insurers from shifting primary responsibility for ESRD care costs to Medicare.
- Clarifies that including a specific dialysis provider in a network is not a requirement.
- Addresses the Medicare Secondary Payer Act (MSPA) to ensure broader protections for ESRD patients.
Who is affected
- Individuals with end-stage renal disease (ESRD)
- Private health insurance companies
- Medicare beneficiaries
- Healthcare providers specializing in renal dialysis
Notable changes
- Strengthens the MSPA to better protect ESRD patients from discriminatory coverage practices.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
76 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours